Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tofacitinib treatment for hair loss may worsen acne.

Keratoacanthoma is a common, usually non-dangerous skin tumor that looks like squamous cell carcinoma but rarely becomes severe.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

TLR2 is important for hair growth and can be targeted to treat hair loss.

An 8-year-old boy with hair-pulling disorder had a bald patch that was confirmed not to be a fungal infection and was treated with therapy.

Temporal triangular alopecia may be linked to sebaceous nevus and shows a new pinkish background feature.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Temporal triangular alopecia is a non-scarring hair loss in children, often linked to other health conditions.

Sox13 is a marker for early hair follicle development but not essential for skin and hair growth.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Congenital triangular alopecia is more common than thought and some treatments can be beneficial for appearance concerns.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

A girl with Becker naevus syndrome has a genetic variant in the ACTB gene related to her symptoms.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

YAP and TAZ proteins control skin cell growth and repair.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Specific brain and bone imaging findings can help diagnose Trichothiodystrophy.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

XEDAR triggers a specific signaling pathway in cells.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.